Am J Trop Med Hyg

1. GARGOURI O, Bouchaala K, Ben Ayed N, Koubaa S, et al
   Prevalence and Resistance Patterns of Pseudomonas aeruginosa in a Tunisian Intensive Care Unit.
   Am J Trop Med Hyg. 2026;114:837-843.
   

   >> Share

   
   

   
   Antimicrob Agents Chemother

2. FABRIZIO C, Valzano F, Giuliano S, Morelli E, et al
   Optimizing target inactivation to treat multidrug-resistant Escherichia coli with NDM and PBP3 mutations: "going the extra mile".
   Antimicrob Agents Chemother. 2026;70:e0088725.
   

   >> Share

   
   
3. SHROPSHIRE WC, Borjan J, Fonseca IY, Pham K, et al
   Clinical and genomic determinants associated with emergent ceftazidime-avibactam plus aztreonam non-susceptibility in ceftazidime-avibactam resistant Escherichia coli.
   Antimicrob Agents Chemother. 2026;70:e0186025.
   

   >> Share

   
   
4. ARASTEHFAR A, Daneshnia F, Hovhannisyan H, Cabrera N, et al
   Multidimensional assessment of in-host fitness costs of echinocandin resistance in the opportunistic fungal pathogen Candida glabrata reveals the niche-specific requirement for FKS1 and FKS2 during infection and gut colonization.
   Antimicrob Agents Chemother. 2026 Mar 23:e0180125. doi: 10.1128/aac.01801.
   

   >> Share

   
   
5. KRANKEL L, Hauser J, Slavetinsky J, Zinser A, et al
   Polygenic, cell-envelope adaptations drive high-frequency daptomycin resistance in Staphylococcus capitis NRCS-A from neonatal sepsis and NEC.
   Antimicrob Agents Chemother. 2026 Mar 24:e0141425. doi: 10.1128/aac.01414.
   

   >> Share

   
   
6. ROYER G, Danjean M, Rodriguez C, Fihman V, et al
   Piperacillin-tazobactam resistance in Klebsiella pneumoniae is often associated with IS26-mediated bla(SHV-1) amplification in a widespread Klebsiella-adapted plasmid.
   Antimicrob Agents Chemother. 2026;70:e0168225.
   

   >> Share

   
   
7. VOLYNKINA IA, Bortyazh MO, Chen C-W, Tereshchenkov AG, et al
   Benzoxaborole-modified azithromycins inhibit translation without inducing ermC expression.
   Antimicrob Agents Chemother. 2026;70:e0153925.
   

   >> Share

   
   
8. KUNZ COYNE AJ, Gray R, Gonnabathula P, May ES, et al
   Comparative in vitro activity of aztreonam-avibactam and aztreonam plus ceftazidime-avibactam against Stenotrophomonas maltophilia complex.
   Antimicrob Agents Chemother. 2026;70:e0145625.
   

   >> Share

   
   
9. ZHOU M, Yang Z, Wang M, Jia R, et al
   Identification and characteristics of a novel acquired aminoglycoside phosphotransferase, APH(3')-IVb, from Riemerella anatipestifer.
   Antimicrob Agents Chemother. 2026;70:e0163125.
   

   >> Share

   
   
10. XI B, Wu Y
    Peroxin Pex8 couples stress responses, antifungal tolerance, and virulence regulation in Candida albicans.
    Antimicrob Agents Chemother. 2026 Mar 24:e0166225. doi: 10.1128/aac.01662.
    

    >> Share

    
    
11. PEREZ-RODRIGUEZ G, Aja-Macaya P, Gonzalez-Pinto L, Taltavull B, et al
    Emergence of KPC-producing Pseudomonas aeruginosa in Spain: insights into an outbreak and resistance to the novel carbapenem/beta-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam.
    Antimicrob Agents Chemother. 2026;70:e0165725.
    

    >> Share

    
    
12. LE ROY C, Guiraud J, Byambaa O, Balcon C, et al
    In vitro selection and characterization of resistance to pristinamycin in Mycoplasma genitalium.
    Antimicrob Agents Chemother. 2026;70:e0009426.
    

    >> Share

    
    
13. YAMADA T, Maeda M, Nakagawa M, Yaguchi T, et al
    The entire CYP51B locus in azole-resistant isolates of the dermatophyte Trichophyton indotineae revealed by optical genome mapping.
    Antimicrob Agents Chemother. 2026;70:e0181725.
    

    >> Share

    
    
14. DOS SANTOS AR, Bonifaz A, Bombassaro A, Machado ACdS, et al
    Establishment of epidemiological cutoff values for clinically relevant Sporothrix species using CLSI-broth microdilution.
    Antimicrob Agents Chemother. 2026;70:e0190725.
    

    >> Share

    
    
15. STELLFOX ME, Doi Y
    Case Commentary: When one target is not enough-PBP3 insertions and target redundancy in Escherichia coli.
    Antimicrob Agents Chemother. 2026;70:e0005326.
    

    >> Share

    
    
16. DORAZIO AJ, Kline EG, Squires KM, Shah S, et al
    Ceftazidime-avibactam resistance evolution in Pseudomonas aeruginosa and implications for cross-resistance to other novel beta-lactams.
    Antimicrob Agents Chemother. 2026;70:e0191025.
    

    >> Share

    
    
17. LU W, Li L, Lin X, Liu D, et al
    Identification and characteristics of a novel fosfomycin glutathione transferase, FosA12, from an MDR clinical isolate of Proteus vulgaris.
    Antimicrob Agents Chemother. 2026;70:e0113825.
    

    >> Share

    
    
18. YANG Z, Zhang Y, Li D, Wang S, et al
    Drug-resistant clinical Candida responded to 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in vitro via enhanced ROS release.
    Antimicrob Agents Chemother. 2026 Apr 17:e0164525. doi: 10.1128/aac.01645.
    

    >> Share

    
    

    
    Int J Antimicrob Agents

19. MUKHOPADHYAY S, Zhang X, To KKW, Liu Y, et al
    Treatment sequences of a phage and colistin combination trigger different evolution pathways of a multidrug-resistant Acinetobacter baumannii yielding distinct treatment outcomes.
    Int J Antimicrob Agents. 2026;67:107745.
    

    >> Share

    
    
20. HUSSEIN M, Allobawi R, Barclay J, Kho ZY, et al
    A window into resistance: The MEGA-plate as a model of evolutionary dynamics.
    Int J Antimicrob Agents. 2026;67:107751.
    

    >> Share

    
    
21. TANG C, Shen S, Han R, Yin D, et al
    Molecular mechanisms and clonal distribution of cefiderocol-resistant bla(NDM)-carrying Escherichia coli: A multi-centre study in China.
    Int J Antimicrob Agents. 2026;67:107762.
    

    >> Share

    
    
22. WANG L, Guo X, Chen Y, Li S, et al
    Causality-informed models for multidrug-resistant organism prediction: Enabling effective ICU antibiotic stewardship.
    Int J Antimicrob Agents. 2026;67:107767.
    

    >> Share

    
    

    
    J Antimicrob Chemother

23. CASTAGNOLA E, Mariani M, Saffioti C, Ricci E, et al
    Artificial intelligence for analysing antibiotic use: an exploratory study in a tertiary care paediatric hospital in Italy.
    J Antimicrob Chemother. 2026;81:dkag162.
    

    >> Share

    
    

    
    J Infect Chemother

24. SATO W, Sedohara A, Ichimura H, Koga M, et al
    Molecular Epidemiology of Treponema pallidum subsp. pallidum among Men Who Have Sex with Men at a HIV Referral Hospital in Tokyo: Multilocus Sequence Typing and Macrolide Resistance.
    J Infect Chemother. 2026 May 1:102984. doi: 10.1016/j.jiac.2026.102984.
    

    >> Share

    
    

    
    J Infect Dis

25. MATTHEWS LG, Vodstrcil LA, Wild NL, Plummer EL, et al
    Declining efficacy of moxifloxacin for Mycoplasma genitalium infection: time for fluoroquinolone-resistance guided therapy?
    J Infect Dis. 2026 May 8:jiag251. doi: 10.1093.
    

    >> Share

    
    

    
    PLoS Comput Biol

26. LIN YS, Wong RC, Yu J, Yang K, et al
    Application of machine learning with MALDI-TOF MS for rapid differentiation between methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    PLoS Comput Biol. 2026;22:e1013760.
    

    >> Share

    
    

    
    PLoS One

27. ABIE S, Abey SL, Dagnaw GG, Molla W, et al
    Methicillin-resistant Staphylococcus aureus along the beef production line: Phenotypic resistance and mecA phylogeny in two ethiopian municipal abattoirs.
    PLoS One. 2026;21:e0334585.
    

    >> Share

    
    

    
    Virology

28. RODEA M GE, Gonzalez-Villalobos E, Espinoza-Mellado MDR, Morales-Garcia MR, et al
    Genomic characterization of a new member of the Phikmvvirus genus infecting multidrug-resistant high-risk clones of Pseudomonas aeruginosa.
    Virology. 2026;620:110775.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share